Table 2.
Relationship of IGF-1 expression and downstream signaling molecule phosphorylation to indexes of muscle size and function
| MHC Protein Content | Leg Muscle Mass | Knee Extensor Isometric Torque | |
|---|---|---|---|
| IGF-1 | −0.104 | −0.495 | −0.198 |
| phospho-Akt/Akt | 0.602* | −0.01 | 0.020 |
| phospho-mTOR/mTOR | 0.481 | 0.136 | 0.535† |
| phospho-GSK-3β/GSK-3β | −0.477 | 0.248 | −0.036 |
| phospho-eIF2Bε/eIF2Bε | −0.10 | −0.320 | −0.370 |
| phospho-eIF4E-BP/eIF4E-BP | 0.02 | 0.053 | 0.184 |
| phospho-p70 S6K/p70 S6K | 0.26 | −0.151 | 0.312 |
Data represent Pearson correlation coefficients. Correlation coefficients for knee extensor isometric torque reflect partial correlation coefficients after the effect of leg muscle mass was statistically removed. Sample sizes for IGF-1 mRNA and signaling molecules are provided in Figs. 1–3. For myosin heavy chain (MHC) protein content, data were not available on 1 female HF patient. mTOR, mammalian target of rapamycin; GSK-3β, glycogen synthase kinase-3β; eIF4E-BP, eukaryotic translation initiation factor 4E binding protein-1; p70 S6K, p70 ribosomal S6 kinase.
P < 0.02,
P < 0.05.